Lactobacillus reuteri
AssigneePrecisionBiotics Group Limited
InventorJens Walter
Life of this patent
Estimating the term…
Abstract
Lactobacillus reuteri strain having NCIMB accession number 42835 is from a novel phylogenetic clade and has unique immune-stimulatory properties and enhanced ecological performance in the human gut. A substrate for the strain, such as raffinose, may be administered at the same time as or separately from the strain.
Claims19
A formulation comprising a strain of Lactobacillus reuteri deposited under NCIMB accession number 42835 mixed with an ingestible carrier, wherein the strain is in the form of a freeze-dried powder, and wherein the formulation is in the form of a capsule, a powder, a food product, or a beverage, the formulation being formulated for oral administration to a subject.
A method of treating a subject to increase gut microbiota diversity, the method comprising administering to the subject a formulation comprising Lactobacillus reuteri strain having NCIMB accession number 42835, wherein the strain is in the form of a freeze-dried powder, and wherein the formulation increases the gut microbiota diversity in the subject.
Dependencies are inferred from the claim text.